Torres-Saavedra, P. A., Breen, S. L., Chan, J. W., Bar-Ad, V., Bednarz, G., Bowles, D. W., Breen, S., Burtness, B., Chakravarti, A., Chan, J., Chung, C., Cmelak, A., Dicker, A. P., Dorth, J., Dunlap, N., El-Naggar, A., Gwede, C. K., Harris, J., Holsinger, F. C., Jones, C. U., Jordan, R. C., Krempl, G. A., Le, Q., Lee, N., Lominska, C., Ma, D. J., Machtay, M., Mell, L. K., Nguyen-Tân, P. F., Quon, H., Raben, A., Rao, S., Samuels, S., Sher, D., Siu, L. L., Spencer, S., Stokes, W. A., Takiar, V., Thorstad, W., Torres-Saavedra, P., Wilke, C. T., Yao, M., Yom, S. S., Young, M. R. (2025). Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01829